BDSX News and Press, Biodesix Inc. From 06/10/25

LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that it is partnering with the Association of Pulmonary Advanced Practice Providers (APAPP) to bring new educational programs aimed at their professional mem...

LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois at 2:30 pm ET on Saturday, May 31...

LOUISVILLE, Colo., May 21, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that members of the Biodesix management team, will participate in two upcoming investor conferences: 22 nd Annual Craig-Hallum Insti...

LOUISVILLE, Colo., May 15, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced that new data will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2025 Annual Meeting in Montreal, Quebec and...

2025-05-14 16:15:04 ET Lake Street analyst issues BUY recommendation for BDSX on May 14, 2025 05:31PM ET. The previous analyst recommendation was Buy. BDSX was trading at $0.22 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...

2025-05-14 16:15:04 ET Canaccord Genuity analyst issues BUY recommendation for BDSX on May 14, 2025 05:31PM ET. The previous analyst recommendation was Buy. BDSX was trading at $0.22 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...

LOUISVILLE, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, is pleased to announce that it is a Colorado Top Workplaces 2025 Winner . The Top Workplaces program has an 18-year history of surveying and celebrating peo...

2025-05-14 12:39:21 ET More on Biodesix Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansio...

2025-05-13 20:22:56 ET More on Biodesix Biodesix, Inc. (BDSX) Q1 2025 Earnings Call Transcript Biodesix, Inc. (BDSX) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Biodesix Historical earnings data for Biodesix Financial infor...

2025-05-13 20:22:08 ET Biodesix, Inc. (BDSX) Q1 2025 Results Conference Call May 13, 2025 04:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call...